Select Publications

Books

Mellick AS, 2006, Lab Ref: A handbook of recipes, reagents, and other reference tools for use at the bench., Mellick AS, (ed.)

Journal articles

Yong J; Hakobyan K; Xu J; Mellick AS; Whitelock J; Liang K, 2023, 'Comparison of protein quantification methods for protein encapsulation with ZIF-8 metal-organic frameworks', Biotechnology Journal, 18, http://dx.doi.org/10.1002/biot.202300015

Yong J; Mellick AS; Whitelock J; Wang J; Liang K, 2023, 'A Biomolecular Toolbox for Precision Nanomotors', Advanced Materials, 35, pp. e2205746, http://dx.doi.org/10.1002/adma.202205746

Chen K; Yong J; Zauner R; Wally V; Whitelock J; Sajinovic M; Kopecki Z; Liang K; Scott KF; Mellick AS, 2022, 'Chondroitin Sulfate Proteoglycan 4 as a Marker for Aggressive Squamous Cell Carcinoma', Cancers, 14, pp. 5564, http://dx.doi.org/10.3390/cancers14225564

Teo WS; Holliday H; Karthikeyan N; Cazet AS; Roden DL; Harvey K; Konrad CV; Murali R; Varghese BA; Thankamony AP; Chan CL; McFarland A; Junankar S; Ye S; Yang J; Nikolic I; Shah JS; Baker LA; Millar EKA; Naylor MJ; Ormandy CJ; Lakhani SR; Kaplan W; Mellick AS; O'Toole SA; Swarbrick A; Nair R, 2020, 'Id Proteins Promote a Cancer Stem Cell Phenotype in Mouse Models of Triple Negative Breast Cancer via Negative Regulation of Robo1', Frontiers in Cell and Developmental Biology, 8, http://dx.doi.org/10.3389/fcell.2020.00552

Wimmer M; Zauner R; Ablinger M; Pinõ´ n-Hofbauer J; Guttmann-Gruber C; Reisenberger M; Lettner T; Niklas N; Proell J; Sajinovic M; De Souza P; Hainzl S; Kocher T; Murauer EM; Bauer JW; Strunk D; Reichelt J; Mellick AS; Wally V, 2020, 'A cancer stem cell-like phenotype is associated with miR-10b expression in aggressive squamous cell carcinomas', Cell Communication and Signaling, 18, http://dx.doi.org/10.1186/s12964-020-00550-9

Cutler SJ; Doecke JD; Ghazawi I; Yang J; Griffiths LR; Spring KJ; Ralph SJ; Mellick AS, 2017, 'Novel STAT binding elements mediate IL-6 regulation of MMP-1 and MMP-3', Scientific Reports, 7, pp. 8526, http://dx.doi.org/10.1038/s41598-017-08581-y

Sax MJ; Gasch C; Athota VR; Freeman R; Rasighaemi P; Westcott DE; Day CJ; Nikolic I; Elsworth B; Wei M; Rogers K; Swarbrick A; Mittal V; Pouliot N; Mellick AS, 2016, 'Cancer cell CCL5 mediates bone marrow independent angiogenesis in breast cancer', Oncotarget, 7, pp. 85437 - 85449, http://dx.doi.org/10.18632/oncotarget.13387

Gasch C; Plummer PN; Jovanovic L; McInnes LM; Wescott D; Saunders CM; Schneeweiss A; Wallwiener M; Nelson C; Spring KJ; Riethdorf S; Thompson EW; Pantel K; Mellick AS, 2015, 'Heterogeneity of miR-10b expression in circulating tumor cells', Scientific Reports, 5, http://dx.doi.org/10.1038/srep15980

Sax M; Plummer PN; Mittal V; Mellick AS, 2014, 'Vascular contribution to metastasis', Cancer Forum, 38, pp. 103 - 107

Li C; Hashimi SM; Cao S; Mellick AS; Duan W; Good D; Wei MQ, 2013, 'The mechanisms of Chansu in inducing efficient apoptosis in colon cancer cells', Evidence-based Complementary and Alternative Medicine, 2013, http://dx.doi.org/10.1155/2013/849054

Plummer PN; Freeman R; Taft RJ; Vider J; Sax M; Umer BA; Gao D; Johns C; Mattick JS; Wilton SD; Ferro V; McMillan NAJ; Swarbrick A; Mittal V; Mellick AS, 2013, 'MicroRNAs regulate tumor angiogenesis modulated by endothelial progenitor cells', Cancer Research, 73, pp. 341 - 352, http://dx.doi.org/10.1158/0008-5472.CAN-12-0271

Li C; Hashimi SM; Good DA; Cao S; Duan W; Plummer PN; Mellick AS; Wei MQ, 2012, 'Apoptosis and microRNA aberrations in cancer', Clinical and Experimental Pharmacology and Physiology, 39, pp. 739 - 746, http://dx.doi.org/10.1111/j.1440-1681.2012.05700.x

Mellick AS; Plummer PN; Nolan DJ; Gao D; Bambino K; Hahn M; Catena R; Turner V; McDonnell K; Benezra R; Brink R; Swarbrick A; Mittal V, 2010, 'Using the transcription factor inhibitor of DNA binding 1 to selectively target endothelial progenitor cells offers novel strategies to inhibit tumor angiogenesis and growth', Cancer research, 70, pp. 7273 - 7282

Gao D; Nolan DJ; Mellick AS; Bambino K; McDonnell K; Mittal V, 2008, 'Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis', Science, 319, pp. 195 - 198, http://dx.doi.org/10.1126/science.1150224

Nolan DJ; Ciarrocchi A; Mellick AS; Jaggi JS; Bambino K; Gupta S; Heikamp E; McDevitt MR; Scheinberg DA; Benezra R; Mittal V, 2007, 'Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization', Genes and Development, 21, pp. 1546 - 1558, http://dx.doi.org/10.1101/gad.436307

Tajouri L; Mellick AS; Tourtellotte A; Nagra RM; Griffiths LR, 2005, 'An examination of MS candidate genes identified as differentially regulated in multiple sclerosis plaque tissue, using absolute and comparative real-time Q-PCR analysis', Brain Research Protocols, 15, pp. 79 - 91, http://dx.doi.org/10.1016/j.brainresprot.2005.04.003

Ghazawi I; Cutler SJ; Low P; Mellick AS; Ralph SJ, 2005, 'Inhibitory effects associated with use of modified Photinus pyralis and Renilla reniformis luciferase vectors in dual reporter assays and implications for analysis of ISGs', Journal of Interferon and Cytokine Research, 25, pp. 92 - 102, http://dx.doi.org/10.1089/jir.2005.25.92

Neuzil J; Tomasetti M; Mellick AS; Alleva R; Salvatore BA; Birringer M; Fariss MW, 2004, 'Vitamin E analogues: A new class of inducers of apoptosis with selective anti-cancer effects', Current Cancer Drug Targets, 4, pp. 355 - 372, http://dx.doi.org/10.2174/1568009043332943

Whitchurch CB; Leech AJ; Young MD; Kennedy D; Sargent JL; Bertrand JJ; Semmler ABT; Mellick AS; Martin PR; Alm RA; Hobbs M; Beatson SA; Huang B; Nguyen L; Commolli JC; Engel JN; Darzins A; Mattick JS, 2004, 'Characterization of a complex chemosensory signal transduction system which controls twitching motility in Pseudomonas aeruginosa', Molecular Microbiology, 52, pp. 873 - 893, http://dx.doi.org/10.1111/j.1365-2958.2004.04026.x

Jenner TL; Mellick AS; Harrison GJ; Griffiths LR; Rose'Meyer RB, 2004, 'Age-related changes in cardiac adenosine receptor expression', Mechanisms of Ageing and Development, 125, pp. 211 - 217, http://dx.doi.org/10.1016/j.mad.2003.11.016

Tajouri L; Mellick AS; Ashton KJ; Tannenberg AEG; Nagra RM; Tourtellotte WW; Griffiths LR, 2003, 'Quantitative and qualitative changes in gene expression patterns characterize the activity of plaques in multiple sclerosis', Molecular Brain Research, 119, pp. 170 - 183, http://dx.doi.org/10.1016/j.molbrainres.2003.09.008

Mellick AS; Blackmore D; Weinstein SR; Griffiths LR, 2003, 'An assessment of MMP and TIMP gene expression in cell lines and stroma-tumour differences in microdissected breast cancer biopsies', Tumor Biology, 24, pp. 258 - 270, http://dx.doi.org/10.1159/000076140

Rose'Meyer RB; Mellick AS; Garnham BG; Harrison GJ; Massa HM; Griffiths LR, 2003, 'The measurement of adenosine and estrogen receptor expression in rat brains following ovariectomy using quantitative PCR analysis', Brain Research Protocols, 11, pp. 9 - 18, http://dx.doi.org/10.1016/S1385-299X(02)00219-2

Mellick AS; Day CJ; Weinstein SR; Griffiths LR; Morrison NA, 2002, 'Differential gene expression in breast cancer cell lines and stroma-tumor differences in microdissected breast cancer biopsies revealed by display array analysis', International Journal of Cancer, 100, pp. 172 - 180, http://dx.doi.org/10.1002/ijc.10451

Hendry IA; Kelleher KL; Bartlett SE; Leck KJ; Reynolds AJ; Heydon K; Mellick A; Megirian D; Matthaei KI, 2000, 'Hypertolerance to morphine in G(z alpha)-deficient mice.', Brain Res, 870, pp. 10 - 19, http://dx.doi.org/10.1016/s0006-8993(00)02387-8

Conference Papers

Brown Y; Jamaluddin MFB; Ghosh A; Mellick AS; Murtha L; Boyle A; Tanwar PS, 2018, 'The Glue of Cancer Cell Life: Characterization of the Acellular Component of High Grade Serous Ovarian Cancer Identifies Potential Novel Drug Targets', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 15 - 15, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000446654600014&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Cutler SJ; Doecke JD; Ghazawi I; Yang J; Mellick AS; Ralph SJ, 2013, 'STAT-1 regulates constitutive and IL-6/PMA-inducible MMP-1 and MMP-3 expression in colorectal cancer via proximal promoter STAT binding elements', in CYTOKINE, ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, CA, San Francisco, pp. 256 - 256, presented at Annual Joint Conference of the International-Cytokine-Society and the International-Society-for-Interferon-and-Cytokine-Research, CA, San Francisco, 29 September 2013 - 03 October 2013, http://dx.doi.org/10.1016/j.cyto.2013.06.059

Ghazawi I; Mellick AS; Cutler SJ; Doecke J; Raleigh J; McArthur G; Ralph SJ, 2013, 'STAT5 activates the C-Myc proximal promoter: Elevated STAT5 or C-Myc expression relative to STAT1 is linked with reduced survival of melanoma patients given IFN gamma therapy', in CYTOKINE, ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, CA, San Francisco, pp. 265 - 265, presented at Annual Joint Conference of the International-Cytokine-Society and the International-Society-for-Interferon-and-Cytokine-Research, CA, San Francisco, 29 September 2013 - 03 October 2013, http://dx.doi.org/10.1016/j.cyto.2013.06.095

Plummer PN; Balsara S; Umer B; Taft R; Ferro V; Mattick JS; Swarbrick A; McMillan N; Mittal V; Mellick AS, 2013, 'MICRORNAS AS NOVEL ANTI-ANGIOGENESIS THERAPEUTIC TARGETS', in JOURNAL OF GENE MEDICINE, WILEY-BLACKWELL, AUSTRALIA, Univ Technol, Sydney, pp. 321 - 322, presented at 8th Meeting of the Australasian-Gene-Therapy-Society, AUSTRALIA, Univ Technol, Sydney, 08 May 2013 - 10 May 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325102500023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Plummer PN; Balsara S; Ferro V; Mittal V; Mellick AS, 2013, 'NANOPARTICLE DELIVERY OF RNA-BASED THERAPY TO MODULATE TUMOUR VASCULATURE: AS A NEXT GENERATION ANTICANCER THERAPY', in JOURNAL OF GENE MEDICINE, WILEY-BLACKWELL, AUSTRALIA, Univ Technol, Sydney, pp. 322 - 323, presented at 8th Meeting of the Australasian-Gene-Therapy-Society, AUSTRALIA, Univ Technol, Sydney, 08 May 2013 - 10 May 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325102500024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mellick AS; Plummer PN; Mittal V, 2013, 'Identification and targeting of small noncoding RNAs implicated in tumor angiogenesis', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Washington, DC, presented at 104th Annual Meeting of the American-Association-for-Cancer-Research (AACR), Washington, DC, 06 April 2013 - 10 April 2013, http://dx.doi.org/10.1158/1538-7445.AM2013-2309

Teo W; Nair R; McFarland A; Ye S; Mellick A; Lakhani S; Swarbrick A, 2012, 'Dissecting the Role of the Inhibitor of Differentiation 1 in Breast Cancer Metastasis and Characterization of Pathways Controlling Breast Cancer Stem Cell Phenotype', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, Barcelona, SPAIN, pp. S37 - S37, presented at 22nd Biennial Congress of the European-Association-for-Cancer-Research, Barcelona, SPAIN, 07 July 2012 - 10 July 2012, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000313036500138&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Plummer PN; Taft R; Mattick J; McMillan N; Swarbrick A; Brink R; Mittal V; Mellick AS, 2011, 'MICRORNAS AS TOOLS TO TARGET BONE MARROW MEDIATED TUMOUR ANGIOGENESIS', in JOURNAL OF GENE MEDICINE, WILEY, AUSTRALIA, Univ Melbourne, Bio21 Inst, Parkville, pp. 430 - 430, presented at 7th Biennial Meeting of the Australasian-Gene-Therapy-Society, AUSTRALIA, Univ Melbourne, Bio21 Inst, Parkville, 04 May 2011 - 06 May 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297950900039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Plummer PN; Taft R; Mattick J; McMillan N; Swarbrick A; Brink R; Mittal V; Mellick AS, 2011, 'MICRORNAS AS TOOLS TO TARGET BONE MARROW MEDIATED TUMOUR ANGIOGENESIS', in JOURNAL OF GENE MEDICINE, WILEY, AUSTRALIA, Univ Melbourne, Bio21 Inst, Parkville, pp. 443 - 443, presented at 7th Biennial Meeting of the Australasian-Gene-Therapy-Society, AUSTRALIA, Univ Melbourne, Bio21 Inst, Parkville, 04 May 2011 - 06 May 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297950900061&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Griffiths LR; Tajouri L; Mellick AS; Tannenberg EG; Tourtellotte WW, 2003, 'Microarray gene expression analyses of multiple sclerosis plaque tissue.', in AMERICAN JOURNAL OF HUMAN GENETICS, UNIV CHICAGO PRESS, CALIFORNIA, LOS ANGELES, pp. 424 - 424, presented at Annual Meeting of the American-Society-of-Human-Genetics, CALIFORNIA, LOS ANGELES, 04 November 2003 - 08 November 2003, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000185599701489&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Rose'Meyer RB; Mellick AS; Harrison GJ; Fenning A; Griffiths LR; Brown L, 2001, 'Measurement of adenosine A(3) receptor expression using real time PCR in rat hypertrophied hearts', in DRUG DEVELOPMENT RESEARCH, WILEY-LISS, AUSTRALIA, GOLD COAST, pp. 563 - 563, presented at 7th International Symposium on Adenosine and Adenine Nucleotides, AUSTRALIA, GOLD COAST, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000179038200093&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Presentations

Sax MJ; Plummer PN; Gasch C; Freeman R; Day CJ; Wei M; Swarbrick A; Mittal V; Mellick AS, 2015, 'Endothelial C-C chemokine receptor type 5 (CCR5) is required for tumor angiogenesis'

Preprints

Chen K; Yong J; Zauner R; Wally V; Whitelock J; Sajinovic M; Kopecki Z; Liang K; Scott K; Mellick AS, 2022, Chondroitin Sulfate Proteoglycan 4 as a Marker for Aggressive Squamous Cell Carcinoma, http://dx.doi.org/10.20944/preprints202211.0160.v1

Wimmer M; Zauner R; Ablinger M; Piñón-Hofbauer J; Guttmann-Gruber C; Reisenberger M; Lettner T; Niklas N; Proell J; Sajinovic M; De Souza P; Hainzl S; Kocher T; Murauer EM; Bauer JW; Strunk D; Reichelt J; Mellick AS; Wally V, 2020, MiRNA-10b marks aggressive squamous cell carcinomas, and confers a cancer stem cell-like phenotype, http://dx.doi.org/10.1101/2020.02.05.934109

Teo WS; Holliday H; Karthikeyan N; Cazet AS; Roden DL; Harvey K; Konrad CV; Murali R; Varghese BA; P. T. A; Chan C-L; McFarland A; Junankar S; Ye S; Yang J; Nikolic I; Shah JS; Baker LA; Millar EKA; Naylor MJ; Ormandy CJ; Lakhani SR; Kaplan W; Mellick AS; O’Toole SA; Swarbrick A; Nair R, 2018, Id proteins promote a cancer stem cell phenotype in triple negative breast cancer via negative regulation of Robo1, http://dx.doi.org/10.1101/497313


Back to profile page